Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model (Q45231654)
Jump to navigation
Jump to search
scientific article published in February 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model |
scientific article published in February 2005 |
Statements
1 reference
Rofecoxib attenuates both primary and secondary inflammatory hyperalgesia: a randomized, double blinded, placebo controlled crossover trial in the UV-B pain model (English)
1 reference
1 reference
Thomas Sycha
1 reference
Sebastian Anzenhofer
1 reference
Stephan Lehr
1 reference
Boris Chizh
1 reference
Hans-Georg Eichler
1 reference
Burkhard Gustorff
1 reference
1 February 2005
1 reference
Identifiers
1 reference